Sana biotechnology announces the acceptance of six abstracts for presentation at the american society of gene and cell therapy (asgct) 26th annual meeting

Seattle, may 02, 2023 (globe newswire) -- sana biotechnology, inc. (nasdaq: sana), a company focused on changing the possible for patients through engineered cells, today announced that six abstracts highlighting preclinical data from the fusogen platform have been accepted for presentation, including two oral presentations, at the american society of gene and cell therapy (asgct) 26th annual meeting taking place may 16-20, 2023 in los angeles, ca.
SANA Ratings Summary
SANA Quant Ranking